DrugPatentWatch Database Preview
Drugs in Development Information for Asunaprevir
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Asunaprevir?
Asunaprevir is an investigational drug.
There have been 38 clinical trials for Asunaprevir.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2015.
The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, and Hepatitis A. The leading clinical trial sponsors are Bristol-Myers Squibb, French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS), and Kirby Institute.
There are twenty-nine US patents protecting this investigational drug and three hundred and twenty-four international patents.
Summary for Asunaprevir
| US Patents | 29 |
| International Patents | 324 |
| US Patent Applications | 43 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2015-07-01) |
| Vendors | 38 |
Recent Clinical Trials for Asunaprevir
| Title | Sponsor | Phase |
|---|---|---|
| Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir | Kirby Institute | Phase 4 |
| Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection | Humanity & Health Medical Group Limited | Phase 2 |
| Daclatasvir, Asunaprevir Plus Ribavirin for HCV Genotype 1b Without NS5A RAV | Kaohsiung Medical University Chung-Ho Memorial Hospital | Phase 3 |
Clinical Trial Summary for Asunaprevir
Top disease conditions for Asunaprevir
Top clinical trial sponsors for Asunaprevir
US Patents for Asunaprevir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Asunaprevir | Start Trial | Method for treating HCV | AbbVie Inc. (North Chicago, IL) | Start Trial |
| Asunaprevir | Start Trial | Hepatitis C virus inhibitors | Bristol-Myers Squibb Company (Princeton, NJ) | Start Trial |
| Asunaprevir | Start Trial | Hepatitis C virus inhibitors | Bristol-Myers Squibb Company (Princeton, NJ) | Start Trial |
| Asunaprevir | Start Trial | Hepatitis C virus inhibitors | Bristol-Myers Squibb Company (Princeton, NJ) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Asunaprevir
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Asunaprevir | Australia | 2014239563 | 2033-03-14 | Start Trial |
| Asunaprevir | Australia | 2015240754 | 2033-03-14 | Start Trial |
| Asunaprevir | Australia | 2016202823 | 2033-03-14 | Start Trial |
| Asunaprevir | Australia | 2016291154 | 2033-03-14 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
